vs

Side-by-side financial comparison of A10 Networks, Inc. (ATEN) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

A10 Networks, Inc. is the larger business by last-quarter revenue ($75.0M vs $66.0M, roughly 1.1× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 16.0%, a 23.4% gap on every dollar of revenue.

A10 Networks, Inc. is an American public company specializing in the manufacturing of application delivery controllers. Founded in 2004 by Lee Chen, co-founder of Foundry Networks, A10 originally serviced just the identity management market with its line of ID Series products. In early 2007, they added bandwidth management appliances. The company had its initial public offering on March 21, 2014, raising $187.5 million.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

ATEN vs SLNO — Head-to-Head

Bigger by revenue
ATEN
ATEN
1.1× larger
ATEN
$75.0M
$66.0M
SLNO
Higher net margin
SLNO
SLNO
23.4% more per $
SLNO
39.4%
16.0%
ATEN

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ATEN
ATEN
SLNO
SLNO
Revenue
$75.0M
$66.0M
Net Profit
$12.0M
$26.0M
Gross Margin
79.6%
98.3%
Operating Margin
17.3%
33.5%
Net Margin
16.0%
39.4%
Revenue YoY
13.4%
Net Profit YoY
134.0%
EPS (diluted)
$0.17
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEN
ATEN
SLNO
SLNO
Q1 26
$75.0M
Q4 25
$80.4M
Q3 25
$74.7M
$66.0M
Q2 25
$69.4M
$32.7M
Q1 25
$66.1M
Q4 24
$74.2M
Q3 24
$66.7M
Q2 24
$60.1M
Net Profit
ATEN
ATEN
SLNO
SLNO
Q1 26
$12.0M
Q4 25
$9.9M
Q3 25
$12.2M
$26.0M
Q2 25
$10.5M
$-4.7M
Q1 25
$9.5M
Q4 24
$18.3M
Q3 24
$12.6M
Q2 24
$9.5M
Gross Margin
ATEN
ATEN
SLNO
SLNO
Q1 26
79.6%
Q4 25
78.7%
Q3 25
80.1%
98.3%
Q2 25
78.9%
97.9%
Q1 25
79.7%
Q4 24
79.9%
Q3 24
80.5%
Q2 24
80.0%
Operating Margin
ATEN
ATEN
SLNO
SLNO
Q1 26
17.3%
Q4 25
18.7%
Q3 25
17.4%
33.5%
Q2 25
14.9%
-20.0%
Q1 25
13.3%
Q4 24
24.8%
Q3 24
15.7%
Q2 24
13.2%
Net Margin
ATEN
ATEN
SLNO
SLNO
Q1 26
16.0%
Q4 25
12.3%
Q3 25
16.3%
39.4%
Q2 25
15.2%
-14.4%
Q1 25
14.4%
Q4 24
24.7%
Q3 24
18.9%
Q2 24
15.8%
EPS (diluted)
ATEN
ATEN
SLNO
SLNO
Q1 26
$0.17
Q4 25
$0.13
Q3 25
$0.17
$0.47
Q2 25
$0.14
$-0.09
Q1 25
$0.13
Q4 24
$0.24
Q3 24
$0.17
Q2 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEN
ATEN
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$57.9M
$498.9M
Total DebtLower is stronger
$219.2M
Stockholders' EquityBook value
$220.8M
$494.8M
Total Assets
$634.4M
$599.9M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEN
ATEN
SLNO
SLNO
Q1 26
$57.9M
Q4 25
$684.6M
Q3 25
$370.9M
$498.9M
Q2 25
$367.4M
$286.8M
Q1 25
$355.8M
Q4 24
$195.6M
Q3 24
$182.1M
Q2 24
$177.1M
Total Debt
ATEN
ATEN
SLNO
SLNO
Q1 26
$219.2M
Q4 25
$218.8M
Q3 25
$218.4M
Q2 25
$218.1M
Q1 25
$217.7M
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
ATEN
ATEN
SLNO
SLNO
Q1 26
$220.8M
Q4 25
$211.5M
Q3 25
$206.2M
$494.8M
Q2 25
$204.0M
$240.1M
Q1 25
$195.9M
Q4 24
$231.8M
Q3 24
$217.3M
Q2 24
$214.4M
Total Assets
ATEN
ATEN
SLNO
SLNO
Q1 26
$634.4M
Q4 25
$629.8M
Q3 25
$620.1M
$599.9M
Q2 25
$607.9M
$332.3M
Q1 25
$606.2M
Q4 24
$432.8M
Q3 24
$407.7M
Q2 24
$397.2M
Debt / Equity
ATEN
ATEN
SLNO
SLNO
Q1 26
0.99×
Q4 25
1.03×
Q3 25
1.06×
Q2 25
1.07×
Q1 25
1.11×
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEN
ATEN
SLNO
SLNO
Operating Cash FlowLast quarter
$2.2M
$43.5M
Free Cash FlowOCF − Capex
$43.5M
FCF MarginFCF / Revenue
65.8%
Capex IntensityCapex / Revenue
3.9%
0.0%
Cash ConversionOCF / Net Profit
0.19×
1.67×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEN
ATEN
SLNO
SLNO
Q1 26
$2.2M
Q4 25
$22.7M
Q3 25
$22.8M
$43.5M
Q2 25
$22.2M
$-12.6M
Q1 25
$17.2M
Q4 24
$25.7M
Q3 24
$20.1M
Q2 24
$12.2M
Free Cash Flow
ATEN
ATEN
SLNO
SLNO
Q1 26
Q4 25
$16.0M
Q3 25
$18.1M
$43.5M
Q2 25
$17.9M
$-12.6M
Q1 25
$12.7M
Q4 24
$23.3M
Q3 24
$16.7M
Q2 24
$8.7M
FCF Margin
ATEN
ATEN
SLNO
SLNO
Q1 26
Q4 25
20.0%
Q3 25
24.2%
65.8%
Q2 25
25.9%
-38.6%
Q1 25
19.2%
Q4 24
31.4%
Q3 24
25.0%
Q2 24
14.5%
Capex Intensity
ATEN
ATEN
SLNO
SLNO
Q1 26
3.9%
Q4 25
8.3%
Q3 25
6.3%
0.0%
Q2 25
6.1%
0.0%
Q1 25
6.8%
Q4 24
3.2%
Q3 24
5.2%
Q2 24
5.8%
Cash Conversion
ATEN
ATEN
SLNO
SLNO
Q1 26
0.19×
Q4 25
2.30×
Q3 25
1.87×
1.67×
Q2 25
2.10×
Q1 25
1.80×
Q4 24
1.40×
Q3 24
1.59×
Q2 24
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATEN
ATEN

Products$44.0M59%
Services$31.0M41%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons